CNS pipeline · person

Michael Hayden, MB, ChB, PhD, FRCP(C), FRSC

Director of Ionis Pharmaceuticals since September 2018 and Chair of its Medical and Science Committee. He is CEO of Prilenia Therapeutics and a Killam Professor at the University of British Columbia, and was previously President of Global R&D and Chief Scientific Officer at Teva Pharmaceuticals.

  • 2 companies

Current roles

Past roles

Appears with

People sharing a company with Michael.

People and affiliation data assembled from public company disclosures, SEC filings, and conference materials — every record source-cited under psychiatrist-authored guardrails.